Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation

Efficacy and safety of bromfenac 0.09% and sodium hyaluronate 0.4% combination therapy, versus placebo in patients with pterygium I–III for clinical signs on ocular inflammation

Eduardo Chávez-Mondragón,1 Claudia Palacio,2 Abraham Soto-Gómez,3 Miguel Villanueva-Nájera,4 Guillermo De Wit-Carter,5 Ruben Suárez-Velasco,6 Leopoldo Baiza-Duran,7 Oscar Olvera-Montaño,7 Patricia Muñoz-Villegas71Fundaci&am...

Full description

Saved in:
Bibliographic Details
Main Authors: Chávez-Mondragón E, Palacio C, Soto-Gómez A, Villanueva-Nájera M, De Wit-Carter G, Suárez-Velasco R, Baiza-Duran L, Olvera-Montaño O, Muñoz-Villegas P
Format: article
Language:EN
Published: Dove Medical Press 2019
Subjects:
Nonsteroidal anti-inflammatory drug
Ocular Surface Disease Index
conjunctival hyperemia
ocular lubricant.
Ophthalmology
RE1-994
Online Access:https://doaj.org/article/b1eaecebcf7d44508539b0f8cd64e37c
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/b1eaecebcf7d44508539b0f8cd64e37c

Similar Items